| Names | |
|---|---|
| Preferred IUPAC name | (2S)-2,6-diaminohexanoic acid; acetic acid |
| Other names | L-Lysine monoacetate Acetic acid L-lysine salt Lysine acetate Lysine ethanoate L-Lysine, acetate (1:1) |
| Pronunciation | /ˌelˈlaɪsiːn əˈsiːteɪt/ |
| Identifiers | |
| CAS Number | 57282-49-2 |
| Beilstein Reference | 1721227 |
| ChEBI | CHEBI:86379 |
| ChEMBL | CHEMBL166822 |
| ChemSpider | 10342253 |
| DrugBank | DB14404 |
| ECHA InfoCard | 100.232.810 |
| EC Number | 2.6.1.21 |
| Gmelin Reference | 13331 |
| KEGG | C00047 |
| MeSH | Lysine |
| PubChem CID | 61477 |
| RTECS number | OJ9275000 |
| UNII | TS5Y27FCHL |
| UN number | UN3335 |
| CompTox Dashboard (EPA) | DTXSID70875992 |
| Properties | |
| Chemical formula | C6H14N2O2·C2H4O2 |
| Molar mass | 189.22 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Characteristic |
| Density | 0.68 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -3.0 |
| Vapor pressure | <0.01 hPa (20 °C) |
| Acidity (pKa) | pKa1 = 2.18, pKa2 = 8.95, pKa3 = 10.53 |
| Basicity (pKb) | pKb: 5.3 |
| Magnetic susceptibility (χ) | -20.5 × 10⁻⁶ cm³/mol |
| Dipole moment | 4.51 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 234.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1317.1 kJ/mol |
| Pharmacology | |
| ATC code | B05XA13 |
| Hazards | |
| Main hazards | Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. |
| Precautionary statements | Wash thoroughly after handling. |
| NFPA 704 (fire diamond) | 1-0-0 |
| Autoignition temperature | 410 °C |
| Lethal dose or concentration | LD50 (oral, rat) > 5000 mg/kg |
| LD50 (median dose) | 5,000 mg/kg (Rat, oral) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 760 mg |
| IDLH (Immediate danger) | Not Listed |
| Related compounds | |
| Related compounds | L-Lysine L-Lysine Monohydrochloride L-Lysine Sulfate L-Lysine Hydrochloride L-Lysine Tartrate |
| Attribute | Details | Manufacturer's Notes |
|---|---|---|
| Product Name | L-Lysine Acetate | This designation is used in commercial, feed, food, and pharmaceutical contexts where the acetate salt is required for formulation or compounding. |
| IUPAC Name | (S)-2,6-diaminohexanoic acid, monoacetate | IUPAC nomenclature reflects the structure typically obtained by neutralizing L-lysine with acetic acid; the monoacetate form is widely manufactured due to physicochemical stability and solubility benefits. |
| Chemical Formula | C6H14N2O2 · CH3COOH | The chemical formula accounts for one mole of L-lysine paired with one mole of acetic acid; small variations may occur if manufacturing targets alternative stoichiometries for specific customer formulations. |
| Synonyms & Trade Names | L-Lysine monoacetate; Lysine acetate; Acetic acid L-lysine salt | Synonyms on packaging, technical data sheets, and shipping documents depend on the application segment and customer convention. Clarity is critical to avoid cross-contamination with other L-lysine salts. |
| HS Code & Customs Classification | 2922.41 | The recommended code for international customs classification is 2922.41 (Lysine and its esters, salts thereof). Changes in national subheadings or ex-codes may apply based on end-use or local import regulations. |
Feed-grade and pharmaceutical-grade L-lysine acetate draw on different feedstocks and process routes. Pharmaceutical grades often begin with fermentation-derived L-lysine hydrochloride, neutralized with highly purified glacial acetic acid. Feed-grade routes can use acetic acid of food grade or higher, with batch finalization parameters set according to intended downstream uses. Impurity profiles, especially trace metals and residual organic acids, are influenced by these choices.
Batch consistency is managed through in-process titration and monitored crystallization endpoints. For customer applications with stringent requirements, ion chromatography is used to profile trace acetate and potential by-products. In pharmaceutical applications, the release criteria include both identity and purity, based on pharmacopeial or buyer-driven requirements. Feed and food segments operate to less restrictive standards but require documentation of key analytes.
The final release standard is based on the grade produced. Food and feed grades permit broader tolerances in moisture content and acetylation ratios. Pharmaceutical-grade material is often mapped to compendial monographs where existing, otherwise defined through bilateral specification agreements. Bulk density, flow behavior, and solubility depend heavily on crystal habit, which itself is process-sensitive. Detailed specifications can be defined according to the product grade.
For end-users in formulations or blending, the key property variations affecting performance include particle size distribution, hygroscopicity, and residual volatile organic compounds. Application requirements for injection or parenteral nutrition make pyrogen, endotoxin, and heavy metal content critical control points. For feed and premix, focus leans to dusting tendency, caking control, and analytical consistency over large-scale production lots.
Grade and process conditions influence how the material must be stored: pharmaceutical and food users may mandate desiccant-packed moisture barrier liners, with monitoring against acetic acid loss or cross-contamination. Feed grade, especially intended for vitamin or amino acid blends, requires tight controls on environment to avoid clumping and maintain free-flowing properties during bulk handling.
In standard industrial batches, L-Lysine Acetate appears as a white to pale crystalline or granular solid. The specific color tone and morphology can shift slightly depending on the crystallization step and residual moisture content. No distinct odor is detected under ambient conditions, which aligns with accepted purity ranges for food and pharmaceutical grades.
The melting range reflects the grade and salt form, with variations present due to residual solvent or water content post-drying. Boiling point is not typically referenced since thermal decomposition precedes boiling under normal processing pressures. Density measurement becomes critical during pneumatic transfer and volumetric dosing—expect observable differences for compacts versus fine powders.
L-Lysine Acetate demonstrates robust chemical stability under ambient warehouse conditions. Exposure to elevated humidity or oxidizing atmospheres can accelerate caking or color changes linked to Maillard-type side reactions. The acetate counter-ion resists hydrolysis under neutral pH, though strong bases or prolonged exposure to oxidizing agents can trigger degradation.
Solubility in water is high for most industrial grades, but dissolution rate correlates to particle size, agglomerate strength, and air content. Product for injectable formulation undergoes additional micronization and sieving to meet strict solubility kinetics. Batchwise, we monitor temperature, agitation, and pH during solution prep to minimize clumping and guarantee process repeatability.
We maintain specification tables customized for feed, food, and pharma grades. Purity, heavy metals, microbial load, and moisture levels are always grade-dependent. Custom specification sheets align with project-specific release criteria set between our quality control and the customer’s requirements.
Key impurities arise from incomplete neutralization, residual mother liquor, and carryover from feedstock lysine. Primary focus sits on controlling organic residuals, inorganic salts, and trace heavy metals. Final impurity profiles always track back to raw material lots, reactor cleaning schedule, and procedural controls in the acetate addition step.
Test methodology for assay, moisture, and trace elements follows internal SOPs, aligned with international compendial procedures when required. Each method carries specific detection limits and validation status, documented batchwise. Final release specification references both in-house and customer-agreed tolerance ranges.
L-Lysine HCl or L-Lysine base typically anchors the raw material supply, purchased from vetted amino acid fermenters. Acetic acid supply is selected for minimized non-volatile residue and micro-contamination risk. Source and lot traceability guarantee downstream reproducibility and product integrity.
We neutralize L-Lysine base with glacial or diluted acetic acid in an aqueous phase, controlling pH, exotherm, and feed ratio. Inadequate control leads to localized overheating, product discoloration, or incomplete conversion. Reaction stoichiometry is constantly monitored to avert off-spec acetic acid residues.
Refined process steps include crystallization, solid-liquid separation, and drying under filtered air. Each stage is equipped with in-process checks for pH, conductivity, and clarity. Impurity removal leverages repeated crystallization or activated carbon treatment if color or odor deviations arise.
Comprehensive QC sampling and statistical batch testing confirm all critical parameters—purity, moisture, and organoleptic properties. Release protocols differ by end use, with pharma grades subject to more stringent microbial and particulate controls. We uphold traceable batch documentation and corrective action triggers if any parameter drifts near upper or lower control limits.
L-Lysine Acetate supports further derivatization on its free epsilon-amino group and backbone carboxyl in lab-scale protocols. Amidation, acylation, and enzymatic coupling proceed under conditions defined by the target molecule.
Catalyst, temperature, and solvent choices depend on downstream process needs. For pharmaceutical intermediate preparation, low-temperature and aqueous compatibility are prioritized to retain chirality and prevent racemization. Most modifications demand stoichiometric control and controlled pH near neutral.
Application sectors–feed, food, or pharma–dictate which derivative route is viable. Some routes target custom peptide synthesis; others seek salt exchange for altered solubility or taste-masking in supplements.
We instruct storage at controlled ambient temperature, shielded from direct sunlight to prevent clumping and oxidative browning. High humidity accelerates caking and diminishes flow properties, especially in high-purity or micronized lots. Nitrogen blanketing is sometimes specified for pharma grades to guard against trace-level oxidation.
Industrial batches ship in food-grade HDPE drums or lined fiber cartons, validated for product compatibility and absence of extractables. For high-sensitivity grades, inner liners and tamper-evident closures prevent ingress of moisture or air.
Shelf life varies by packaging, residual moisture, and product grade. Typical signs of degradation include discoloration, loss of crystallinity, and the development of an off-odor. We recommend rotation strategies that log receipt date and mandate first-in, first-out consumption.
Classification specifics depend on grade and end-use. Most L-Lysine Acetate lots do not fall under acute toxicity hazards at industrial exposure levels but always reference the actual Safety Data Sheet per batch for compliance purposes.
Process operators apply dust control and respiratory protection during powder transfer. Housekeeping protocols address potential slip or inhalation risks. The acetate component mildly irritates mucous membranes in high concentrations.
Existing animal and in-vitro data indicate generally low acute toxicity for lysine and its acetate salt. Chronic exposure assessments rely on ongoing toxicological evaluation; batch variation is tracked in case new impurity profiles emerge.
Exposure guidelines are set according to national occupational limits or customer site preferences. Handling focuses on minimizing dust, segregating food/pharma lots from industrial run-off, and ensuring traceable batch accountability in contamination incident investigation.
Production capacity for L-Lysine Acetate is directly determined by the continuous fermentation throughput of primary amino acid plants and subsequent downstream acetate conversion, which relies on consistent upstream glucose feed and acetic acid quality. Multi-grade production lines support broad output flexibility, but improvements in fermentation yield, media optimization, and recovery efficiency remain central to stable volumes. Output allocation shifts with animal feed and food additive segment demand. Upgrades to bioreactor automation and crystallization systems in recent years have shortened conversion cycle times, but total annual plant availability remains contingent on scheduled maintenance and local permitting for emissions and water use.
Lead times fluctuate with campaign scheduling, seasonality of raw input procurement, and order customization requirements. Typical shipment preparation follows campaign-driven batch production, with minimum order quantities reflecting process lot sizes and logistical consolidation to minimize spillage and exposure. MOQ varies according to application sector, with larger runs in animal nutrition and smaller, specification-controlled batches for pharmaceutical and specialty food use. Lead times extend when demand outpaces routine slotting or when technical grade changes require line cleaning or re-validation.
Packaging decisions follow grade requirements and downstream handling infrastructure. Bulk feed-grade product is typically filled in woven bags with moisture barrier liners, while specialty and pharmaceutical grades often use multi-layered composite drums or high-integrity PE containers to protect against humidity ingress and cross-contamination. Detailed drum and liner specifications are defined with customer input to fit filling lines, regulatory transport requirements, and traceability systems.
Shipping modes span bulk containerized ocean freight for high-volume feedlots, air or LCL for low-volume, high-grade segments. Most customers select EXW, FOB, or CIF per local import/re-export constraints. Payment terms reflect risk profile, credit history, and trading relationship duration. Letters of credit, partial prepayment, or open account are selected based on transaction value, country, and payment assurance needs.
Raw material costs for L-Lysine Acetate production are mainly driven by market pricing for feedstock glucose, sourced from corn or cassava depending on region and crop cycle, and acetic acid, derived from different petrochemical or fermentation routes. Corn-based glucose input costs fluctuate with global grain harvests, bioethanol sector demand, and regional weather impacts. Acetic acid prices move with methanol cost volatility, refinery run rates, and environmental regulation enforcement on production emissions. Process water, utilities, direct labor, and maintenance add variable overhead, but fermentation broth yield loss and crude purity strongly affect effective conversion cost.
Notable cost swings occur during feedstock supply disruptions, raw input export controls, or crude oil price surges affecting acetic acid derivatives. Regulatory changes on input certification and residue limits can trigger requalification runs, lifting conversion costs temporarily. Price difference among L-Lysine Acetate grades stems from bio-process refinement steps: pharmaceutical and food grades require repeated crystallization, finer filtration, and tighter impurity controls (especially with residual protein, metals, endotoxins), while technical and feed grades demand larger batch runs, more relaxed impurity specs, and cost-optimized process settings. Packaging and documentation costs scale with grade sensitivity and export certification needs.
Product price increments reflect the depth of purification, additional QA testing, traceability batch segregation, and packaging conformity for GxP, GMP+, FSSC 22000, or FAMI-QS compliance. Higher purity and documented batch history command premiums, as does any special packaging validated for food/pharma distribution under global logistics schemes. Lower-grade, uncoated feed use product runs are priced closer to raw input volatility.
Global L-Lysine Acetate output closely tracks protein ingredient demand, especially as animal feed fortifiers in Asia, North America, and Europe. Feed and food sectors seek consistent supply as livestock nutrition standards rise. The expansion of amino acid fortification in plant-based protein and specialty foods supports steady volume draw in the US and EU. Japan remains a high-grade, low-volume importer, focusing on pharma additive purity. India is ramping up local conversion capacity, but retail pricing remains influenced by regional glucose cost cycles and import tariffs. China’s dominant fermentation footprint secures influence over global benchmark prices, but anti-dumping enforcement, currency shifts, and environmental regulations alter export patterns.
| Region | Industrial Focus | Price Sensitivity |
|---|---|---|
| US | Animal nutrition, plant-based foods; seeks traceable supply chain | Moderate: multi-source; seasonal swings with Midwest corn |
| EU | Feed, food additives, pharma co-formulants | High: strict residue, cross-border certification required |
| JP | Pharma and specialty food; quality-focused | Very high: process audit and full documentation needed |
| IN | Emergent feed processing; building local supply | High: raw input constraint, import duties impact price |
| CN | Breadth of grades; global exporter | Variable: market-setting, but subject to regulatory clampdown |
Short and mid-term L-Lysine Acetate pricing continues to draw from commodity grain and chemical volatility, major policy moves on agricultural exports, and regulatory tightening on environmental emissions in Northeast Asia. Capacity expansions in India and Southeast Asia promise to narrow price gaps, but global benchmark levels will respond to both currency fluctuations and coordinated plant maintenance cycles in leading regions. Premiums for ultra-high purity or certified specialty packaging are projected to widen as global traceability and documentation standards move upward. Process optimization and increased fermentation efficiency may dampen some cost pass-through by 2026, but raw input risk will remain core.
Internal pricing analysis incorporates actual raw material indexation (FOB/EXW glucose, acetic acid cost references), public commodity pricing feeds, bilateral trade volume data, and customer order pattern monitoring. Ongoing engagement with local regulatory bodies and peer facility benchmarking supplements our outlook models.
Recent trade disputes, weather disruptions in key grain-producing countries, and pushback on petrochemical feedstock pricing have placed irregular pressure on spot and contract pricing. New regional plant start-ups in India and Thailand reported, focused on captive feed integration to alleviate reliance on imports. Several anti-dumping claims raised against selected exporters have shifted export focus toward contract logistics over spot shipments.
Ongoing amendments to animal feed additive regulations in North America and the EU continue to raise the bar on dioxin, heavy metal, and cross-contaminant scrutiny. Certifications such as GMP+, FAMI-QS, and FSSC 22000 see increasingly stringent audit intervals, driving suppliers to strengthen batch traceability, in-process cleaning validations, and product release documentation.
Production departments are rotating input supplier audits and increasing the share of direct sourcing agreements to ensure feedstock continuity. Multi-grade blending and tailored purification streams are used to match segment-specific requests while minimizing overall batch changeover loss. Investments in process water recycling, volatiles capture, and online QC diagnostics are prioritized to buffer against regulatory shocks and market volatility.
L-Lysine Acetate supports demand across feed premix, pharmaceutical synthesis, food fortification, fermentation, and specialty chemical intermediates. Our production team observes the most significant differentiation in formulation and quality requests among feed, pharma, and food ingredient supply chains. Each sector prioritizes different parameters according to regulatory requirements and purity standards; thus, product grade tightly connects to application end-use, as outlined below.
| Industry Sector | Suited Grades | Main End-use Considerations |
|---|---|---|
| Feed Additives | Feed Grade | Focus on high lysine content, tolerance for minor residuals from fermentation-based routes, and cost control. Colormetric controls maintained but not to pharma or food standards. Large batch sizes prioritized. |
| Pharmaceuticals | Pharma Grade | Strict limits set for inorganic, organic, and microbial impurities. Contaminant screening and process traceability required. Batches validated through compendial test references. Full trace chain for audits. |
| Food Ingredients | Food Grade | Specifications regulated by regional food safety authorities. Heavy metal, solvent residue, and microbiological benchmarks enforced. Allergen risk controlled at selection and handling steps. |
| Bioprocess & Fermentation | Technical/High Purity Grade | Chemical compatibility and metabolic impact assessed batch-wise. Low ionic, organic, or endotoxin contamination levels controlled at purification stage, customized for specific bioprocess applications. |
Field technical support starts by collecting application and intended regulatory market. Product purity, impurity risk, and physical handling needs get mapped from this information. Feed integrators, pharma compounding facilities, and food blenders display unique requirements which are incompatible in a one-grade-fits-all strategy.
Regulatory audit trail begins at raw material sourcing, confirmed at final QC release. Pharma grade demands full documentation for each processing batch, including process water and cleaning agent controls. Food grade complies with local or global food safety systems, meeting all contaminant and allergen controls. Feed grade adheres to livestock and non-human regulations, with flexibility on non-critical trace elements.
Technical consultations with the customer clarify tolerance for impurities and non-lysine actives. Pharma and fermentation users frequently request analytical data on trace contaminants. Feed customers weigh price-to-content, accepting slightly lower purification provided lysine bioavailability is secured. Our lab provides lot-based certificates for all routes.
Batch size, route of supply, and end-use economics shape both production batch and packaging mode. Feed grade fills demand for bulk, low-cost, high-throughput distribution. Pharma and food grades produced in smaller validated lots with additional in-process control and rigorous packaging standards. Secondary packaging and traceable labeling requirements captured during order discussion.
Pre-delivery validation sampling provides both sides with critical performance and compatibility data. End-user can trial actual production lot against formulation, downstream process, or blending scheme. Customer QC shares results with our technical team to close any application match gaps before contract batch agreement. Final supply release always subject to mutual QC signoff and documentation exchange.
Continuous process control, precise documentation practices, and routine internal audits form the backbone of our quality management system. Audited annually against international quality standards, our management system includes dedicated teams for preventive action reporting and supplier qualification. All raw material batches pass a documented approval process before use. On-site inspectors validate every batch, enforcing traceability at each processing stage.
Grade selection determines the relevant certifications supplied with each L-Lysine Acetate lot. For industrial and feed applications, inspection routines address purity, residual solvents, and microbiological limits where applicable. Customers in regions requiring feed additive approval or production under GMP-like conditions will find our documentation set aligned with their regulatory environment. Request for specialty grades, such as those formulated for biopharmaceutical or food-contact uses, requires prior discussion to align final product release with both manufacturer and end-user requirements.
Our technical package includes detailed Certificate of Analysis for each production lot, batch-specific test reports, and process flow diagrams for audit supporting purposes. Regular updates on change management and process control improvements are sent to contract manufacturing customers. Stability reports and application validation data can be supplied by arrangement. Typical values, impurity profiles, and grade-specific release criteria are reviewed in accordance with evolving customer requirements and global regulatory standards.
L-Lysine Acetate output relies on controlled upstream fermentation capacity and in-house purification lines. Advanced demand forecasts and feedstock reservation contracts minimize the risk of supply interruptions. For multi-regional or high-frequency buyers, we support tailored offtake schedules and contract manufacturing terms to accommodate fluctuations in demand or seasonal requirements. Custom packaging, labeling, and documentation can be integrated into regular supply plans subject to operational lead time confirmation.
Production scheduling runs on batch or continuous operation, adjusted per market volume commitments and downstream formulation needs. Core equipment redundancy and backup utility systems are maintained to minimize exposure to process downtime. Forward integration into distribution ensures stable logistics even during peak season or regional disruptions. Contract holders with firm offtake agreements receive priority allocation during constrained raw material scenarios.
Technical sample requests require clarity on desired grade, target application, and specification priorities. The technical team reviews each inquiry and coordinates with QC and production for short-run batches if non-standard parameters are required. Accompanying documentation includes certificate of analysis and available compliance records relevant to the intended application domain. Support for scaled industrial trials or regulatory filings can be discussed as part of the initial sample supply dialogue.
We support direct purchase orders, annual supply agreements, and specialty tolling or private-label arrangements. These modes are structured around customer production cycles, regulatory schedules, and anticipated reformulation efforts. Multi-site or cross-border supply chains may benefit from staggered deliveries, advanced allocation, or consignment inventory solutions. Payment and delivery terms can be negotiated to match operational and financial planning, subject to credit approval and contract performance history.
Current projects in L-Lysine Acetate center on increasing process efficiency, improving batch yield, and reducing residual by-products that accumulate during synthesis. Most technical teams use fermentation or enzymatic conversion as the main synthetic route, with process optimization focusing on reducing the step count and simplifying downstream purification. Specific interest remains in minimizing color-forming impurities and reducing volatile organic content, both of which can affect performance for injection-grade or nutritional applications.
Research teams continuously evaluate bio-based raw input sourcing—particularly the quality and trace composition of carbohydrate feedstocks—since microbial productivity strongly affects consistency. Pilot studies often trial slight pH or temperature deviations, enzyme variants, or filtration adjustments, noting knock-on effects on both lysine assay and acetate levels in the finished product.
Applications development looks closely at injectable formulations, specialized feed blends, and nutraceuticals where chloride avoidance is required. Formulation scientists ask for acetate salt due to lower chloride interference in some cell culture media or injectable solutions. New trials also include L-Lysine Acetate as a stabilizer for biopharmaceutical active ingredients, requiring ultra-low endotoxin levels. In food processing, premium-grade grades attract formulators in specialized protein enrichment and fermentation substrate applications where sodium content must be strictly controlled.
Key hurdles remain in precise acetate to lysine ratio management, end-of-batch color minimization, and bulk stability for extended storage or high-humidity transport. On-site teams emphasize that even slight contamination from upstream fermentation steps can cascade into purification bottlenecks. In-process monitoring and filtration innovations in the last two years have yielded reductions in color release and easier compliance for injectable and ultrapure requirements. Installation of advanced chromatography and membrane purification allows more reliable removal of pyrogenic and proteinaceous residuals prior to final packaging.
Near-term market outlook reflects robust demand from animal nutrition, pharmaceutical, and cell culture sectors. Technical grade remains predominant, with food and pharma grades showing accelerated volume growth for specialty and export markets. Orders from bioprocessing clients suggest a stable, moderate growth trajectory, with two-stream demand: bulk feed and high-purity pharma. Price and volume volatility appears linked to raw input commodity cycles, while the global shift to alternative protein sources supports stable demand.
Ongoing investments in membrane separation and high-resolution chromatography are expected to further reduce impurity profiles and improve batch uniformity. Teams plan to trial continuous processing paradigms, targeting higher batch turnover and in-line analytics to replace post-process testing. Real-time impurity tracking and predictive batch adjustment promise to lower rework rates, especially for the most stringent pharma applications. Projects in enzymatic catalysis and selective crystallization are gaining traction for their potential to enhance energy and water efficiency in core production steps.
Sustainability benchmarks focus on lowering solvent use, improving water recovery, and utilizing bio-based or waste-derived carbohydrate feedstocks where feasible. Sourcing shifts aim for agricultural by-products with consistent trace composition to safeguard fermentation yields and minimize off-quality episodes. Teams examine ways to integrate closed-loop process water cycles and valorize fermentation side streams, aligning with green chemistry principles. Process audits and lifecycle assessments guide raw material qualification and help identify steps where solvent or auxiliary input reduction will yield measurable reductions in environmental burden.
Technical advisors handle direct discussions on grade selection, process route compatibility, and impurity consideration for every batch. Field engineers are available to interpret certificate of analysis data, explain batch-to-batch differences, and guide on regulatory or compendial alignment when required for food or pharma grade projects. Consultation extends to feed and pharmaceutical formulators aiming to manage salt balance, solubility, and compatibility in multi-component systems.
Support teams routinely help clients fine-tune formulation and mixing parameters, especially when optimizing for solubility, dispersibility, or reactivity under specific process conditions. Process experts can recommend pre-conditioning steps, solubility buffers, or filtration improvements based on actual downstream plant trials. Assistance includes evaluation of new application settings, from trial-scale to full-scale transfer, with feedback cycles that incorporate real-world performance data back into quality improvement.
After delivery, dedicated support follows every batch with stability monitoring, long-term sample retention, and full traceability. Quality assurance provides access to reserved retention samples in the event of long-lag performance issues. If a client notes outlier performance, technical and quality control collaborate on root-cause investigation, adjusting in-process controls or batch composition as dictated by joint review. Commitment extends to updating clients on process evolution or specification changes driven by regulatory shifts, ensuring application continuity and long-term supply security.
L-Lysine Acetate leaves our production facility as a result of tight controls and ongoing process optimization. Our technical teams run continuous batch and inline analysis systems, verifying purity and particle specifications at every stage. Clear process definition enables targeted intervention if routine data points indicate a potential drift. This direct line between production floor and laboratory puts immediate focus on results, not just compliance charts. Our experience in scaling batch volumes translates into batch reproducibility. Whether filling standard drums or custom totes, every dispatch links back to origin batch records with full traceability.
Industrial formulators turn to L-Lysine Acetate for nutritional fortification, pH adjustment, and as a precursor for synthesis. Compound feed producers rely on lysine sources with stable assay values, as deviations slow down their blending lines. Pharmaceutical processors require dependable consistency, as minor shifts can impact downstream granulation and tablet output. Fermentation and biochemical industries value lysine’s functional contribution within enzyme production and probiotic lines. In each context, product stability translates to fewer interruptions and reduced re-testing.
We control the full production chain from raw material intake through finished packing. Automated feeders, controlled crystallization, and modern drying systems reduce manual intervention and build consistency at every point. Real-time monitoring of moisture content, free acid levels, and particle distribution provides actionable feedback long before packing begins. Sampling at multiple points in each lot gives a direct read on batch uniformity. Our QA technicians compare statistical controls for every shipping lot against process norms, triggering batch holds whenever corrective checks are warranted.
Our output capacity meets high-volume industrial needs, supported by robust packing and logistics lines. We operate multi-format filling lines, providing L-Lysine Acetate in 25kg bags, 500kg FIBCs, or sealed HDPE drums. Industrial buyers avoid the disruptions that come from insufficient warehousing and unpredictable delivery cycles. Each container ships with a batch-specific certificate of analysis drawn from our in-house analytical labs. Integration with leading logistics partners ensures regular supply schedules for both contract and spot customers.
Downstream application support forms a core part of our business practice. Production chemists and technical liaisons work closely with buyers’ technical teams, sharing processing advice and troubleshooting support based on actual plant experience. Whether a client requires blending suggestions for a new nutritional premix or guidance on pH impact in fermentation media, our team shares knowledge built on direct manufacturing data. Our process and R&D specialists engage in joint reviews of application feedback, enabling product adjustments and test runs tailored to emerging process needs.
Procurement managers value reliable order fulfillment and access to technical resources. Close integration between manufacturing, quality control, and distribution allows buyers to project costs and process requirements without routine disruptions. Contract customers benefit from direct product tracking and shipping schedules that tie back to actual output at the factory, not third-party schedules. For commercial partners handling sensitive applications, the difference derives from working with a producer who controls not only inventory levels but also the full technical profile of every lot shipped.
Direct engagement with production—from the lab bench to the packing line—creates accountability and product assurance rarely matched by intermediaries. Ongoing investment in equipment, automated lines, and staff training means each batch of L-Lysine Acetate meets the published specification, not just an average across shipments. For industrial and commercial buyers, partnering with a factory team yields operational clarity, quality assurance, and consistent delivery within complex supply environments.
Producing L-Lysine Acetate takes careful handling at every step, from our raw material procurement to the last stages of purification and packaging. Over the years, we have adjusted our process to prioritize both purity and reliable assay values, because these factors determine how well the ingredient performs in your formulations. We keep our focus squarely on consistency, because a fluctuating active content invites downstream problems for both food and pharmaceutical clients.
Clients often want to know not just the guaranteed minimum, but also the typical result they can expect. Our L-Lysine Acetate production consistently achieves assay values of 98.0% or above (calculated on a dry basis), measured using validated in-house methods anchored to pharmacopeial standards. A typical lot leaves our facility with actual purity in the 98–101% range. We keep water content and residuals under close control, as excess moisture or by-products compromise both shelf life and further processing.
Uniformity across batches makes planning and compliance far simpler for downstream users. Our investment in advanced separation and crystallization technology allows us to maintain this. If a customer sees significant deviation from their spec, production headaches and costly overages follow in their blenders and reactors. Years of process improvement have aimed at this narrow window to balance efficiency with purity.
Feed, food, and pharmaceutical sectors require unwavering assurance. High assay translates to predictable biological performance, whether the destination is an intravenous solution, an amino acid blend, or a bio-fermented feed additive. Misjudging actual purity leads to either underdosing or waste through unnecessary fortification. Repeated analytical checks—both during and after crystallization—let us catch deviations long before the product ever sees a shipping drum.
Our approach keeps total impurities tightly controlled. In qualifying lots for release, we monitor not just lysine content but also levels of ammonia, acetate, and heavy metals using in-house equipment. Typical total impurity content remains low, supporting pharmaceutical applications that demand a strict impurity profile. We understand regulatory focus on elemental impurities, particularly in Europe and North America, and our technical team has kept control levels below prevailing regulatory triggers.
Ingredient needs continue to evolve. Some customers require audit trails on amino acid profiles, traceable to botanical starting materials. Others ask for extra-tight moisture control, or certified suitability for food–contact applications. Our facility can offer both standard and custom testing, from HPLC for identity down to UV and wet chemistry for trace analytes. Not every client needs this, but we keep these capabilities ready for projects with heightened sensitivity—because the first signs of contamination or process drift often lie in these analytical details.
Being factory-direct means control and responsibility flow from process floor to customer dock. Specifications are set by what our lines can achieve consistently, not a catalog pulled from somewhere else. Every release lot comes with a full certificate of analysis, tied to physical retention samples in our own QA rooms. If a customer or regulator asks about test method, batch genealogy, or trace contamination data, our technical team provides answers drawn from primary records and batch histories.
L-Lysine Acetate stands as a foundation ingredient for a range of industries. Reliable assay and high purity simplify life for formulators and procurement teams. As manufacturing challenges shift, we adapt by refining our purification and analytics to keep ahead of both regulatory trends and real-world process demands. For anyone with a challenging spec or a new regulatory question, we stand ready to answer from a direct producer’s perspective with firsthand data.
As a direct manufacturer of L-Lysine Acetate, we recognize just how critical packaging formats and timelines are to production planning. Our packaging choices come from decades of conversations with purchasing managers, technical directors, and sourcing specialists who need bulk quantities to keep their operations moving. Standard packaging for industrial applications centers around heavy-duty woven bags—typically 25 kg or 20 kg net weight—with PE liners to protect product integrity. For larger-scale consumption, we routinely fill 500 kg or 1000 kg big bags. These flexible intermediate bulk containers are designed to withstand rough shipping, provide moisture protection, and simplify mechanical handling within manufacturing plants or warehouses.
Consistent, quality-driven packaging isn’t just convenient; it’s essential. Our production team selects bagging materials that have consistently passed strength, puncture, and seal testing because failures spell delays and rework for both us and our customers. This approach keeps product loss to a minimum, particularly during transoceanic shipments or high-humidity storage. We avoid using packaging that creates static, causes caking at the bottom, or complicates automated unloading. Reliable packaging enables continuous dosing, reduces material handling footprint, and cuts the risk of cross-contamination.
Lead time for L-Lysine Acetate depends most on volume and destination. For repeat orders within our regular monthly schedule, we maintain a rolling base stock. Under standard circumstances, preparation for shipment requires about 10 to 14 days. This window includes material production, QA testing, lot release, and final bagging. For customers requesting custom packaging formats or private labeling, extra days are added as print runs and approvals are coordinated. Export destinations might face administrative customs hold-ups, but our shipping coordinators have the route planning experience to minimize paperwork surprises.
Seasonal demand swings and raw material supply volatility are realities in amino acid manufacturing. To keep our promise of timely delivery, we operate a staggered batch schedule and maintain up-to-date raw material contracts. This upstream planning prevents last-minute disruptions from rippling through the supply chain. We hold stocks of both finished goods and key intermediates in dedicated warehouses, supporting urgent dispatches when surges from feed, pharma, or fermentation customers exceed forecasts. Our system tracks every order milestone in real time—from formulation to shipping container loading—which means buyers always have visibility into their procurement status.
Some applications—specialty feed, laboratory-scale prototyping, or nutraceuticals—might call for smaller or custom batch sizes. While our primary flows prioritize larger packs, we accommodate these where technically feasible. For any request deviating from our mainstream packaging, our tech and production teams evaluate feasibility within our capacity plan. Lead times for non-standard pack sizes might increase, but clear and direct communication avoids guesswork. We also provide certificates of analysis, packaging photos, and compliance documentation along with every consignment, supporting users who navigate strict regulatory regimes.
Our manufacturing team treats every order as a promise—not just of chemical quality, but of professional reliability. We back up this commitment with robust material traceability, documented QA, and straightforward logistics tracking. In bulk procurement, consistency and integrity mean more than simply filling bags; they demand planning, experience, and partnership from factory floor to end-user. Each packaging and shipment solution arises from years at the factory, not copy-paste templating. Our direct approach keeps communication efficient and expectations aligned, keeping our L-Lysine Acetate customers running without interruption.
Years of operating our own synthesis and purification facilities have taught us the value of absolute compliance. L-Lysine Acetate plays an important role in pharmaceutical, nutraceutical, and veterinary markets, where specifications are tightly defined. Our process steps and finished material undergo strict quality reviews specifically tuned to match pharmacopeia monographs—USP, EP, JP—as referenced by our customers. Each production batch is tested in-house using validated methods such as titration for assay, HPLC for purity, and rigorous microbiological analysis. Results are documented in batch certificates and retained for full traceability.
Compliance never comes from simply copying text from standards. Our in-process and finished goods testing draws on deep technical training. For L-Lysine Acetate, attention covers identification, content determination, loss on drying, heavy metal restrictions, and microbiological safety. Audits—from our own internal team and from customer QA—repeatedly review our lab protocols and production logs. Our quality systems carry ISO certifications, and our lab analysts study both current pharmacopoeias and new revisions as they appear, adjusting methods when revisions demand.
Global shipments of L-Lysine Acetate, especially for regulated applications, require clear, comprehensive paperwork. Our documentation package includes certificates of analysis referencing batch laboratory results, with methods directly matching the relevant pharmacopeia chapters. We prepare material safety data sheets (SDS) that fulfill GHS and region-specific requirements. For export shipments, we supply certificates of origin and, when needed, free sale or TSE/BSE statements. Our logistics team manages dangerous goods classification when required (though for L-Lysine Acetate, this is typically not classified as hazardous under standard transport regimes). We use temperature and humidity monitors for sensitive shipments.
Our technical and regulatory staff monitor the latest transport and customs rules affecting amino acids. Updates from authorities such as the FDA, EMA, PMDA, and customs bodies are factored into documentation and processes without delay. This keeps border clearances efficient and avoids delays or technical hold-ups at the destination. Direct communication with freight forwarders and customs brokers helps solve potential compliance challenges before they reach our customer.
Supplying compliant L-Lysine Acetate is not a box-checking exercise. Investments in in-house instrumentation, ongoing analyst training, and direct customer feedback drive our improvements. When pharmacopeia requirements evolve, we update our in-house monographs and batch release criteria. We invite customer audits and supply all source documents for review—raw data, validation studies, and traceability logs.
Our goal from the production floor to the finished goods warehouse is simple: deliver L-Lysine Acetate whose compliance, safety profile, and traceability live up to the promises we print on paper. Every shipment leaving our factory includes a complete set of regulatory and quality documentation, originated and signed by our own technical staff. We back every sale with technical support—rooted in hands-on manufacturing, not just what’s written in a specification. This keeps our L-Lysine Acetate recognized worldwide as fit for critical regulated applications.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
